A Melbourne-based start-up spun out of the Peter MacCallum Cancer Centre has raised $10 million for the further development of its novel cancer immunotherapy that targets solid tumours such as breast and pancreatic cancers.
The Brandon Capital Partners-managed Medical Research Commercialisation Fund led the investment into biotech Currus Biologics, along with university commercialisation fund Uniseed,
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
